Keywords: medeva, results, crown, five, years, growth, share
Medeva's 1994 Results Crown Five Years Of Growth
Article | 27 March 1995
Medeva's share price rose to 196 pence last week on the back of its announcement of better-than-expected financial results for 1994 (Marketletter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
